Literature DB >> 29608428

Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?

Joselaine Ida Cruz1, Solange Aparecida Nappo2.   

Abstract

The low efficacy of crack cocaine addiction treatment available in Brazil has led Brazilian users to find alternatives to reduce drug consumption or even to reach abstinence. One of them is the use of entheogenic substances, like ayahuasca, an infusion obtained from two native plant species from the Amazon. The present report aimed to understand how crack cocaine users recover from drug addiction by consuming ayahuasca tea in a religious context. This is a qualitative study with a purposeful sample of 40 crack cocaine users, based on in-depth, semi-structured interviews. Participants reported that ayahuasca allowed them to access a consciousness dimension which enabled them to solve problems and traumas and reduce crack cocaine consumption. The religious ceremony increased the user's spirituality and the reception from the community gave them a sense of self-esteem, strengthening them in an emotional and social way. That positive experience has been incorporated into the daily routine of most participants. Findings indicate that ayahuasca, in a religious context, may have therapeutic value for crack cocaine dependence treatment.

Entities:  

Keywords:  Ayahuasca; crack cocaine dependence; crack cocaine user; entheogenic substances; treatment

Mesh:

Substances:

Year:  2018        PMID: 29608428     DOI: 10.1080/02791072.2018.1447174

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  2 in total

1.  Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples.

Authors:  Gabriela de Oliveira Silveira; Rafael Guimarães Dos Santos; Felipe Rebello Lourenço; Giordano Novak Rossi; Jaime E C Hallak; Mauricio Yonamine
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

2.  Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine.

Authors:  David M O'Shaughnessy; Ilana Berlowitz; Robin Rodd; Zoltán Sarnyai; Frances Quirk
Journal:  Ther Adv Psychopharmacol       Date:  2021-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.